| 21st Dec 2016 4:17 pm |
RNS |
Issue of Equity & Total Voting Rights |
| 21st Dec 2016 3:05 pm |
RNS |
Result of GM |
| 19th Dec 2016 5:58 pm |
RNS |
Holding(s) in Company |
| 8th Dec 2016 7:45 am |
RNS |
Holding(s) in Company |
| 5th Dec 2016 7:00 am |
RNS |
Publication of circular and notice of GM |
| 1st Dec 2016 5:27 pm |
RNS |
Issue of Equity |
| 25th Nov 2016 11:32 am |
RNS |
Holding(s) in Company |
| 24th Nov 2016 1:36 pm |
RNS |
Holding(s) in Company |
| 23rd Nov 2016 5:12 pm |
RNS |
Holding(s) in Company |
| 23rd Nov 2016 4:56 pm |
RNS |
Closing of public offer |
| 18th Nov 2016 12:51 pm |
RNS |
Confirms successful European placing |
| 18th Nov 2016 7:16 am |
RNS |
US Pricing and European Placing to raise US$25m |
| 4th Nov 2016 1:34 pm |
RNS |
Holding(s) in Company |
| 4th Nov 2016 1:20 pm |
RNS |
Holding(s) in Company |
| 31st Oct 2016 7:00 am |
RNS |
Update on US Public Offering |
| 31st Oct 2016 7:00 am |
RNS |
New Data on Iclaprim |
| 31st Oct 2016 7:00 am |
RNS |
Data Confirming Standard Clinical Trial Dosage |
| 16th Sep 2016 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 16th Sep 2016 4:35 pm |
RNS |
Price Monitoring Extension |
| 15th Sep 2016 7:00 am |
RNS |
Posters presented at IDWeek New Orleans |
| 14th Sep 2016 11:15 am |
RNS |
Issue of Equity |
| 8th Sep 2016 7:00 am |
RNS |
Re-negotiation of the terms of the CPNs |
| 8th Sep 2016 7:00 am |
RNS |
UPDATE ON REVIVE-1 PHASE 3 CLINICAL TRIAL |
| 26th Aug 2016 7:00 am |
RNS |
Chief Medical Officer presents at congress in USA |
| 22nd Aug 2016 4:31 pm |
RNS |
Director/PDMR Shareholding |
| 16th Aug 2016 7:00 am |
RNS |
Half-year Report |
| 9th Aug 2016 5:24 pm |
RNS |
Holding(s) in Company |
| 9th Aug 2016 7:00 am |
RNS |
Update on timing of proposed US Public Offering |
| 5th Aug 2016 7:00 am |
RNS |
Holding(s) in Company |
| 1st Aug 2016 2:15 pm |
RNS |
Result of General Meeting |
| 28th Jul 2016 4:22 pm |
RNS |
Preliminary prospectus filed |
| 18th Jul 2016 4:38 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jul 2016 7:01 am |
RNS |
Circular to allot shares for proposed US Offering |
| 13th Jul 2016 7:01 am |
RNS |
Notice of Intention to List on NASDAQ by Motif Bio |
| 13th Jul 2016 7:00 am |
RNS |
Files For Proposed U.S. Public Offering |
| 1st Jul 2016 7:00 am |
RNS |
Directorate Change |
| 2nd Jun 2016 3:37 pm |
RNS |
Result of AGM |
| 1st Jun 2016 7:00 am |
RNS |
CEO to Present at BIO 2016 |
| 24th May 2016 7:00 am |
RNS |
Investor presentation |
| 28th Apr 2016 7:03 am |
RNS |
Re. Amphion Innovations plc |
